PureTech Health announces first patient dosing in Celea phase 3 trial
13th Jul 2026 10:17
(Alliance News) - PureTech Health PLC on Monday said its founded entity Celea Therapeutics has announced the first dosing in a phase 3 trial. Read More
| Price | 123.20p on 13-07-2026 at 18:35:11 |
|---|---|
| Change | 3.20p 2.67% |
| Buy | 124.00p |
| Sell | 123.80p |
| Last Trade: | Buy 79,213.00 at 123.20p |
| Day's Volume: | 458,025 |
| Last Close: | 123.20p |
| Open: | 120.40p |
| ISIN: | GB00BY2Z0H74 |
| Day's Range | 120.20p - 124.80p |
| 52wk Range: | 104.80p - 148.00p |
| Market Capitalisation: | £299.89m |
| VWAP: | 123.35542p |
| Shares in Issue: | 243.42m |
PureTech (PRTC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 79,213 | 123.20p | Suspected BUY Trade |
16:35:13 - 13-Jul-26 |
| Buy* | 3,250 | 124.00p | Automatic Execution |
16:29:14 - 13-Jul-26 |
| Buy* | 109 | 124.20p | Automatic Execution |
16:28:17 - 13-Jul-26 |
| Buy* | 492 | 124.20p | Automatic Execution |
16:28:17 - 13-Jul-26 |
| Buy* | 157 | 124.20p | Automatic Execution |
16:27:45 - 13-Jul-26 |
| Buy* | 484 | 124.20p | Automatic Execution |
16:27:45 - 13-Jul-26 |
| Buy* | 395 | 124.1429p | Ordinary |
16:27:40 - 13-Jul-26 |
| Buy* | 640 | 124.2855p | Ordinary |
16:19:43 - 13-Jul-26 |
| Buy* | 329 | 124.20p | Automatic Execution |
16:18:12 - 13-Jul-26 |
| Buy* | 227 | 124.20p | Automatic Execution |
16:18:11 - 13-Jul-26 |
PureTech (PRTC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Jul 2026 7:00 am | RNS | PRTC: Celea Doses 1st Patient in Phase 3 IPF Trial |
| 9th Jul 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 2nd Jul 2026 7:01 am | RNS | PRTC Launches Celea w/ $180M & Top Tier Syndicate |
| 2nd Jul 2026 7:00 am | RNS | PRTC Launches Celea: $180M & Asset Transfer |
| 10th Jun 2026 5:38 pm | RNS | Result of AGM |
| 9th Jun 2026 7:00 am | RNS-R | PRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data |
| 4th Jun 2026 5:37 pm | RNS | Holding(s) in Company |
| 29th May 2026 5:00 pm | RNS | Holding(s) in Company |
| 27th May 2026 5:30 pm | RNS | Holding(s) in Company |
| 22nd May 2026 5:00 pm | RNS | Holding(s) in Company |